Identification and Comparison of Metabolites After Oral Administration of Essential Oil of Ligusticum chuanxiong or its Major Constituent Ligustilide in Rats

Abstract

The rhizome of Ligusticum chuanxiong Hort. is a well-known traditional Chinese medicinal herb that is widely used to treat various vascular diseases. The aims of this study were to identify and compare the metabolites in rats after the oral administration of the essential oil of Ligusticum chuanxiong Hort. or its major constituent ligustilide monomer, and to explore the differences in the metabolism of the main active constituent monomer and the active constituent group. High-performance liquid chromatography with diode array detection was used to analyze the metabolites in the urine, feces, and bile of rats dosed with the essential oil or ligustilide. We observed clear differences in the metabolism of the essential oil and ligustilide. The other chemical constituents in the essential oil influenced the metabolism of the main active constituent monomer. Four metabolites in urine were separated, purified, and identified as 6,7-dihydro-6,7-dihydroxyligustilide (M1), 3,5-dihydroxy-3-butylphthalide (M2), 6,7-dihydro-6-hydroxy-7-sulfmethylligustilide (M3), and 5-hydroxy-3-butylidenephthalide (M4) by FT-ICR-MS and ¹H-NMR. M2 and M3 are novel metabolites. Based on the profiles of these metabolites, the pathway of ligustilide metabolism in rats is proposed.

Abbreviations

FTICR:Fourier transform ion cyclotron resonance

M1:metabolite 1

M2:metabolite 2

M3:metabolite 3

M4:metabolite 4

TCM:traditional Chinese medicine

Key words

Ligusticum chuanxiong Hort. - Umbelliferae - essential oil - ligustilide - metabolism - FT-ICR-MS

References

• 1 Yang J R, Li Z L, Hu R, Song J. The antipyretic effect of the essential oil of Ligusticum chuanxiong Hort. on endotoxin-induced fever and hypothalamic content of 5-HT, DA in rabbit.  Sichuan Physiol Sci. 2001;  23 130-1
• 2 Yang J R, Li Z L, Hu R, Song J. The antipyretic effect of the essential oil of Ligusticum chuanxiong Hort. on endotoxin-induced fever and hypothalamic content of monoamine neurotransmitter in rabbit.  Pharmacol Clin Chin Mater Med. 2003;  19 17-9
• 3 Li Z L, Yang J R, Hu R, Song J. Studies on the antipyretic effect and the mechanism of the essential oil of Ligusticum chuanxiong Hort.  Inf Trad Chin Med. 2003;  20 31-2
• 4 Liu L, Ning Z HQ, Shan S, Zhang K, Deng T, Lu X P. et al . Phthalide lactones from Ligusticum chuanxiong inhibit lipopolysaccharide-induced TNF-α production and TNF-α-mediated NF-κB activation.  Planta Med. 2005;  71 808-13
• 5 Xin Z hM, Zhou X M. Studies on pharmacological action and clinical application of preparation of Chuanxiong.  Hebei Med J. 1999;  21 41-2
• 6 Hou D P, Zhang W, Kang T J. The discussion of drug property and clinical application of Chuanxiong.  J Chin Med Pharmacol. 1996;  1 44-5
• 7 Wei Q X, Zhou D W. The pharmacological and pharmacodynamic action of Chuanxiong.  World Notes Plant Med. 1994;  9 164-6
• 8 Ozaki Y, Sekita S, Harada M. Centrally acting muscle relaxant effect of phthalides (ligustilide, cnidilide and senkyunolide) obtained from Cnidium officinale Makino.  Yakugaku Zasshi. 1989;  109 402-6
• 9 Gao L H, Hu J, Zheng X M, Zhang W G, Wei Z W. Stability of Chuanxiong extract and its influence on blood platelet aggregation in rabbit.  Pharm Care Res. 2004;  4 215-7
• 10 Shi Y M, Zhang Y L, Zheng H M. Empirical study and clinical application of activating blood circulation to dissipate blood stasis action of Chuanxiong.  Med J Chin PLA. 1979;  4 98-103
• 11 Liang R X, Xiao Y Q, Gao W. Chuanxiong-pathalide A-induced preconditioning in isolated Langendorff rat hearts.  Pharmacol Clin Chin Mater Med. 2004;  20 1-3
• 12 Liang M J, He L C, Yang G D. Screening, analysis and in vitro vasodilatation of effective components from Ligusticum chuanxiong. .  Life Sci. 2005;  78 128-33
• 13 Tian J W, Fu F H, Jiang W L, Wang C hY, Sun F, Zhang T P. Protective effect of Ligusticum chuanxiong phthalides on focal cerebral ischemia in rats and its related mechanism of action.  China J Chin Mater Med. 2005;  30 466-8
• 14 Chen Y H, Mo S Z, Li J Y, Ge F H. Study on chemical constituents of Rhizoma Chuanxiong volatile oil.  J Chin Med Mater. 2004;  27 580-2
• 15 Hong Y, Ji F. A study of the volatile chemical ingredients in Ligusticum chuanxiong Hort.  China Pharm. 2003;  12 31-2
• 16 Ding M Y, Ma S W, Liu D L. Comparison of volatile oil in Ligusticum chuanxiong and Angelica sinensis. .  Life Sci Instrum. 2005;  3 38-41
• 17 Du J, Yu Y, Ke Y, Wang C, Zhu L, Qian Z M. Ligustilide attenuates pain behavior induced by acetic acid or formalin.  . 2007;  112 211-4
• 18 Naito T, Kubota K, Shimoda Y, Sato T, Ikeya Y, Okada M. et al . Effects of constituents in a Chinese crude drug, Ligusticum chuanxiong rhizoma on vasoconstriction and blood viscosity.  Nat Med. 1995;  49 288-92
• 19 Lu Q, Qiu T Q, Yang H. Ligustilide inhibits vascular smooth muscle cell proliferation.  Eur J Pharmacol. 2006;  542 136-40
• 20 Cao Y X, Zhang W, He J Y, He L C, Xu C B. Ligustilide induces vasodilatation via inhibiting voltage dependent calcium channel and receptor-mediated Ca²⁺ influx and release.  Vascul Pharmacol. 2006;  45 171-6
• 21 Chan S SK, Cheng T Y, Lin G. Relaxation effects of ligustilide and senkyunolide A, two main constituents of Ligusticum chuanxiong, in rat isolated aorta.  J Ethnopharmacol. 2007;  111 677-80
• 22 Yan R, Ko N L, Li S L, Tam Y K, Lin G. Pharmacokinetics and metabolism of ligustilide, a major bioactive component in Rhizoma Chuanxiong, in the rat.  Drug Metab Dispos. 2007;  36 400-8
• 23 Pharmacopoeia Commission of P RC. Pharmacopoeia of the People’s Republic of China (Part 1).  Beijing: Chemical Industry. Press;  2005 Appendix X D 57
• 24 Naito T, Katsuhara T, Niitsu K, Ikeya Y, Okada M, Mitsuhashi H. Two phthalides from Ligusticum chuangxiong. .  Phytochemistry. 1992;  31 639-42
• 25 Bellina F, Ciucci D, Vergamini P, Rossi R. Regioselective synthesis of natural and unnatural (Z)-3-(1-alkylidene) phthalides and 3-substituted isocoumarins starting from methyl 2-hydroxybenzoates.  Tetrahedron. 2000;  56 2533-45